These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35397522)

  • 1. Ten-year atherosclerosis cardiovascular disease (ASCVD) risk score and its components among an Iranian population: a cohort-based cross-sectional study.
    Zibaeenejad F; Mohammadi SS; Sayadi M; Safari F; Zibaeenezhad MJ
    BMC Cardiovasc Disord; 2022 Apr; 22(1):162. PubMed ID: 35397522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.
    Yeboah J; Polonsky TS; Young R; McClelland RL; Delaney JC; Dawood F; Blaha MJ; Miedema MD; Sibley CT; Carr JJ; Burke GL; Goff DC; Psaty BM; Greenland P; Herrington DM
    Circulation; 2015 Sep; 132(10):916-22. PubMed ID: 26224808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk score overestimation: the impact of individual cardiovascular risk factors and preventive therapies on the performance of the American Heart Association-American College of Cardiology-Atherosclerotic Cardiovascular Disease risk score in a modern multi-ethnic cohort.
    DeFilippis AP; Young R; McEvoy JW; Michos ED; Sandfort V; Kronmal RA; McClelland RL; Blaha MJ
    Eur Heart J; 2017 Feb; 38(8):598-608. PubMed ID: 27436865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arterial Stiffness as a Predictor of the Index of Atherosclerotic Cardiovascular Disease in Hypertensive Patients.
    Chang G; Hu Y; Ge Q; Chu S; Avolio A; Zuo J
    Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36833532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort.
    DeFilippis AP; Young R; Carrubba CJ; McEvoy JW; Budoff MJ; Blumenthal RS; Kronmal RA; McClelland RL; Nasir K; Blaha MJ
    Ann Intern Med; 2015 Feb; 162(4):266-75. PubMed ID: 25686167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the European and US guidelines for lipid-lowering therapy in primary prevention of cardiovascular disease.
    Delabays B; de La Harpe R; Vollenweider P; Fournier S; Müller O; Strambo D; Graham I; Visseren FLJ; Nanchen D; Marques-Vidal P; Vaucher J
    Eur J Prev Cardiol; 2023 Nov; 30(17):1856-1864. PubMed ID: 37290056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Coronary Artery Calcium Scoring to Guide Statin Therapy Allocation According to Risk-Enhancing Factors: The Multi-Ethnic Study of Atherosclerosis.
    Patel J; Pallazola VA; Dudum R; Greenland P; McEvoy JW; Blumenthal RS; Virani SS; Miedema MD; Shea S; Yeboah J; Abbate A; Hundley WG; Karger AB; Tsai MY; Sathiyakumar V; Ogunmoroti O; Cushman M; Savji N; Liu K; Nasir K; Blaha MJ; Martin SS; Al Rifai M
    JAMA Cardiol; 2021 Oct; 6(10):1161-1170. PubMed ID: 34259820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 2013 ACC/AHA 10-year atherosclerotic cardiovascular disease risk index is better than SCORE and QRisk II in rheumatoid arthritis: is it enough?
    Ozen G; Sunbul M; Atagunduz P; Direskeneli H; Tigen K; Inanc N
    Rheumatology (Oxford); 2016 Mar; 55(3):513-22. PubMed ID: 26472565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between change in cardiovascular risk scores and future cardiovascular disease: analyses of data from the Whitehall II longitudinal, prospective cohort study.
    Lindbohm JV; Sipilä PN; Mars N; Knüppel A; Pentti J; Nyberg ST; Frank P; Ahmadi-Abhari S; Brunner EJ; Shipley MJ; Singh-Manoux A; Tabak AG; Batty GD; Kivimäki M
    Lancet Digit Health; 2021 Jul; 3(7):e434-e444. PubMed ID: 34167764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclinical Atherosclerosis, Statin Eligibility, and Outcomes in African American Individuals: The Jackson Heart Study.
    Shah RV; Spahillari A; Mwasongwe S; Carr JJ; Terry JG; Mentz RJ; Addison D; Hoffmann U; Reis J; Freedman JE; Lima JAC; Correa A; Murthy VL
    JAMA Cardiol; 2017 Jun; 2(6):644-652. PubMed ID: 28315622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular disease risk prediction by the American College of Cardiology (ACC)/American Heart Association (AHA) Atherosclerotic Cardiovascular Disease (ASCVD) risk score among HIV-infected patients in sub-Saharan Africa.
    Mosepele M; Hemphill LC; Palai T; Nkele I; Bennett K; Lockman S; Triant VA
    PLoS One; 2017; 12(2):e0172897. PubMed ID: 28235058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort.
    Kavousi M; Leening MJ; Nanchen D; Greenland P; Graham IM; Steyerberg EW; Ikram MA; Stricker BH; Hofman A; Franco OH
    JAMA; 2014 Apr; 311(14):1416-23. PubMed ID: 24681960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing Level of Agreement for Atherosclerotic Cardiovascular Disease Risk Categorization Between Coronary Artery Calcium Score and the American College of Cardiology/American Heart Association Cardiovascular Prevention Guidelines and the Potential Impact on Treatment Recommendations.
    Isma'eel H; Min D; Al-Shaar L; Hachamovitch R; Halliburton S; Gentry J; Griffin B; Schoenhagen P; Phelan D
    Am J Cardiol; 2016 Nov; 118(10):1480-1485. PubMed ID: 27642113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of 2013 AHA/ACC ASCVD risk scores with behavioral characteristics of an urban cohort in India: Preliminary analysis of Noncommunicable disease Initiatives and Research at AMrita (NIRAM) study.
    Menon VP; Edathadathil F; Sathyapalan D; Moni M; Don A; Balachandran S; Pushpa B; Prasanna P; Sivaram N; Nair A; Vinod N; Jayaprasad R; Menon V
    Medicine (Baltimore); 2016 Dec; 95(49):e5542. PubMed ID: 27930551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihyperlipidemic Medication Treatment Patterns and Statin Adherence Among Patients with ASCVD in a Managed Care Plan After Release of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol.
    Bellows BK; Olsen CJ; Voelker J; Wander C
    J Manag Care Spec Pharm; 2016 Aug; 22(8):892-900. PubMed ID: 27459651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk and added values of the atherosclerotic cardiovascular risk enhancers on prediction of cardiovascular events: Tehran lipid and glucose study.
    Hadaegh F; Asgari S; Moosaie F; Orangi M; Sarvghadi F; Khalili D; Azizi F
    J Transl Med; 2021 Jan; 19(1):25. PubMed ID: 33407576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atherosclerotic Cardiovascular Disease Risk Estimates Using the Predicting Risk of Cardiovascular Disease Events Equations.
    Anderson TS; Wilson LM; Sussman JB
    JAMA Intern Med; 2024 Aug; 184(8):963-970. PubMed ID: 38856978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary Prevention With Statins: ACC/AHA Risk-Based Approach Versus Trial-Based Approaches to Guide Statin Therapy.
    Mortensen MB; Afzal S; Nordestgaard BG; Falk E
    J Am Coll Cardiol; 2015 Dec; 66(24):2699-2709. PubMed ID: 26700832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atherosclerotic cardiovascular disease risk assessment and predictors of statin use in Filipino-American Women.
    Borja-Hart N; Graff JC; Nolan VG; Wang J; Cooper-DeHoff RM; Ancheta IB
    J Clin Pharm Ther; 2019 Aug; 44(4):632-639. PubMed ID: 30963623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Life's Essential 8 is associated with atherosclerotic cardiovascular disease but not venous thromboembolism in men: a prospective cohort study.
    Isiozor NM; Laukkanen JA; Voutilainen A; Bensenor IM; Kunutsor SK
    Ann Med; 2023 Dec; 55(1):2233894. PubMed ID: 37459575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.